Skip to Main Content

Confused by the the sheer volume of executive orders, official statements, and tweets emanating from the White House? STAT biotech reporter Damian Garde and D.C. correspondent Dylan Scott have been gathering intel from insiders and industry execs. Here’s what they’ve pieced together:

Trump is shifting on pharma

This was the debate in Washington after Trump’s meeting with drug executives: Has the fiery populist already become more of a pragmatist when it comes to drug prices?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!